The fortuitous discovery in 1961 of a laboratory rat with diabetes insipidus (01) in Brattleboro, Vermont, U.S.A., has led to the development of a strain of rats with the disease. Much of the initial work on these Brattleboro rats with Dr was completed by Valtin and his colleagues who showed that the abnormally high water-intakes and urine volumes could be corrected by the administration of the antidiuretic hormone, arginine vasopressin (A VP). However, the defect could not be corrected by short periods of fluid deprivation, the administration of nicotine or hypertonic saline, or the stress of infection-stimuli known to cause the release of A VP from the posterior pituitary (Valtin & Schroeder, 1964) . These workers concluded that since the actual administration of the hormone could correct the abnormality the defect had to be either in the releasing-mechanism for the hormone from the posterior pituitary, or in its synthesis in the hypothalamus.
Anatomical studies and bioassays of hypothalamic and posterior pituitary extracts by Valtin, Sawyer & Sokol (1965) indicated that the defect resided not in the neurohypophyseal releasing-mechanism but in the synthesis of vasopressin in the hypothalamus, a finding later confirmed by Jones & Lee (1967) and Lee & Williams (1972) . The defect was shown to be due to autosomal recessive genes located at a single pair of loci (Saul, Garrity, Benirschke & Valtin, ] 968). As a result of all these findings the rat is generally referred to as the (homozygous) Brattleboro rat with hereditary hypothalamic diabetes insipidus, and as such has been used as an experimental model in the study of the control of water balance by vasopressin, and also in the study of the mechanisms of action of various antidiuretic drugs. Certain observations have however been made which, for want of other explanation, implicate the Brattleboro Dr rat as an 'ideal' experimental model for diabetes insipidus research.
The aim of this review is therefore to consider briefly some of the interesting observations made in experiments completed in this laboratory using the Brattleboro Dr rat. Laycock & Williams (1973) .
Effects of'Pitressin'
The primary action of vasopressin is renal, resulting in an increased reabsorption of water from the distal tubules and collecting ducts. The effects of various doses of the hormone, administered as 'Pitressin tannate in oil' ('Pitressin' consisting of a mixture of porcine and bovine vasopressins in an unspecified proportion; Parke, Davis & Co., Usk Road, Pontypool, NP4 8YH) on urine volumes, urine osmolalities and total solute output are shown in Fig. 1 . The mean control urine volume for untreated Brattleboro DI rats was 80 ± 3 ml/100g/24h, and as the daily dose of 'Pitressin' was increased, the urine volumes decreased accordingly, reaching values comparable to those measured in normal heterozygous Brattleboro rats with the dose of 1000 mu/ 24h. Corresponding increases in urine osmolality occurred with the same doses of 'Pitressin' reaching a mean value of 1402 ± 55 m osmol/kg water with the 1000 mu/24h dose; a value again corresponding to that of untreated heterozygous rats, but less than the values generally reported for untreated Long-Evans rats, usually about 2000 m osmol/kg water (Miller & Moses 1971) or the standard laboratory Wi star rat (e.g. Gottschalk & Mylle, 1959) . Whereas dehydration for 72h is sufficient to raise the urine osmolality of the heterozygous Brattleboro rat from about 1400 to 3500 m osmol/kg water, a similar period of dehydration to Brattleboro DI rats treated with 1000 mu 'Pitressin'/ 24h had no significant effect on the urine osmolality (Lee & Williams, 1972) . In an attempt to reproduce the increase in urine osmolality observed following 72 h dehydration, heterozygous Brattleboro rats were treated daily for nine days with 1000 mu 'Pitressin' (Laycock & Williams, 1973) . Urine osmolalities were only increased significantly on the 8th and 9th days of treatment, and even then the maximum urine osmolalities measured were less than 2000m osmol/kg water. These results indicated that dehydration appeared to' act by a mechanism independent of vasopressin, in the Brattleboro rat, and also that the 'Pitressin'-treated DI rats failed to respond to the dehydration stimulus. One explanation for these observations might be that the Brattleboro DI rat has some renal defect, in addition to the failure to synthesize vasopreSSIn.
The effect of the various doses of 'Pitressin' on the total solute excretion expressed as a percentage of the mean control period value which was taken to be 100% (due to the large degree of animal variation during the control period) is also shown in Fig. 1 . Decreases in the total solute output were apparent for doses of 100-1000 mu 'Pitressin'/24h but only with the 1000 mu dose was the decrease statistically significant (P<0·05). The insignificant increase observed with the 25 mu/24h dose could be due to the injection-volume, this being 0·1 ml instead of 0·2 ml used for all other doses; differences in absorption-rate or other local tissue factors could then account for the discrepancy. Since 1000 mu 'Pitressin' /24h appeared to be the dose of hormone required to restore water-balance to normal heterozygous rat levels, the excretion of individual solutes (sodium, potassium and urea) was also investigated at this dose level (Laycock & Williams, 1973) . Sodium excretion was significantly decreased (P>0'05) on 10 of the 13 days of treatment to an average of 55 % of control values (from 1·8 to l'O mmoljlOOgj24h).
Similarly urea excretions were decreased by an average of 50 % of control values. In contrast, however, potassium excretion only decreased significantly on 2 out of the 13 days of treatment (days 9 and 12). The significant and sustained reductions in sodium and urea excretions occurred at a time when the urine osmolality was reaching values comparable to those of untreated heterozygous rats. It was of interest that Williams (1972) had shown that despite this reduction in solute excretion there was no apparent change in food intake.
From these results it was concluded that assuming the urea transport in the nephron is passive, the reduction in urea excretion is probably secondary to an increased permeability of the collecting duct to this solute (see Morgan & Berliner, 1968) . Since the decreased urea excretion was not transient it appeared that there must be a rise in plasma urea concentration, a change in protein metabolism, or an increased extrarenal loss of this solute.
For the sustained decrease in sodium excretion, assuming an active transport mechanism for this ion, 5 possible mechanisms by which the reduction might occur were considered by Laycock & Williams (1973) . These were: 1. a reduction in tubular flow rate through the collecting duct secondary to the vasopressin-induced increase in the permeability of the distal nephron to water could allow more time for sodium reabsorption; 2. vasopressin might directly stimulate sodium transport out of the distal nephron; 3. aldosterone production could be stimulated, this hormone then increasing the sodium reabsorption from the distal convoluted tubule; 4. there might be a reduction in some circulating natriuretic factor; 5. a reduction in vasa recta flow which would allow for a greater quantity of sodium to be maintained in the closed circuit system at the expense of sodium excretion.
Of these 5 possible mechanisms, the 2nd appeared to be the most favourable since there is other evidence which favours the suggestion that vasopressin might directly affect sodium transport.
For instance Helman, Grantham & Burg (1971) and Frindt & Burg (1972) observed that vasopressin increases sodium transport in the mammalian collecting duct; Atherton, Green & Thomas (1971) showed that vasopressin increases the papillary content of sodium in the water-loaded normal rat; and Lee & Williams (1972) observed that 'Pitressin' increased the sodium concentration of the papillary interstitial fluid. Another interesting aspect was the apparent amount of vasopressin required to restore water balance of Brattleboro DI rats to normal heterozygous rat levels. Originally, Harrington & Valtin (1967) suggested that 500 mu 'Pitressin'j 24h administered to Brattleboro DI rats was sufficient to restore the water balance. Lee & Williams (1972) and Laycock & Williams (1973) concluded that the correct daily dosage of 'Pitressin' was of the order of 1000 mu. In 1971 Miller & Moses, using a radioimmunoassay technique, showed that the urinary excretions of endogenous vasopressin from normal Long-Evans (parent strain) rats, heterozygous Brattleboro rats and the homozygous Dr Brattleboro rats were positively correlated to their urinary osmolalities.
These workers estimated the urinary excretion of the hormone from Long-Evans rats eating and drinking ad libitum to be of the order of 4·5 muj24h. Laycock & Williams (1973) studied the urinary excretions of exogeneous vasopressin at various dose levels up to 1000 mu 'Pitressin'/24h
in Brattleboro Dr rats using a bioassay technique (Fig. 2 ). An excretion of 4,5 mu of antidiuretic activity/24h would appear to correspond to the daily administration of some 450 mu 'Pitressin'/24h, a dose which according to our results was not capable of restoring the water balance of the Dr rat to normal rat levels. However, with the daily dose of 1000 mu 'Pitressin'/24h, the excretion of antidiuretic activity rose to 7·4 mu/24h, this quantity being far in excess of amounts usually detected in normal rat urines. Such values were only obtained in normal rat urines following a severe 96h dehydration in experiments by Dicker & Nunn (1957) . It would therefore appear that a greater dose of vasopressin (as 'Pitressin') than would be anticipated must be administered to Brattleboro OJ rats to restore renal function to ranges found in normal rats . 
Effects of chlorpropamide
Some interesting observations have also been made in our laboratory concerning studies on the mechanism of action of certain antidiuretic drugs.
Chlorpropamide, a member of the sulphonylureas, is one such drug although it is better known for its hypoglycaemic properties in the treatment of diabetes mellitus.
Its mode of action here is generally considered to be by direct stimulation of the~-cells of the islets of Langerhans, since it fails to have any effect in depancreatized animals. Arduino, Ferraz & Rodriguez (1966) reported on the successful treatment of some patients with diabetes insipidus. Since that date, along with confirmation by various workers of these results, various mechanisms of action have been postulated.
These include 1. a direct action on the renal tubules similar to that of vasopressin; 2. a potentiating action on small amounts of circulating vasopressin; 3. an action either at the hypothalmic and/or posterior pituitary levels such that synthesis and/or release of vasopressin is increased; 4. a primary antidipsic effect. The drug has been shown to have no effect whatsoever when administered alone to the Brattleboro DI rat (e.g. Miller & Moses, 1970) but it has been claimed to potentiate the antidiuresis induced by submaximal amounts of exogeneous vasopressin in this experimental animal (Berndt, Miller, Kettyle & Valtin, 1970; Miller & Moses, 1970) . The potentiating action for chlopropamide on small amounts of circulating vasopressin thus became the more generally favoured mechanism of action for this drug. However, as Ettinger & Forsham (1970) pointed out, there appears to be a large discrepancy between the antidiuresis observed in many patients with DI which can be quite large, and the relatively minute antidiuresis induced in the presence of exogeneously administered vasopressin, in studies made on isolated toad-bladder preparations (Mendoza, 1969) as well as in the Brattleboro DI rat. Various experiments were therefore completed in our laboratory to ascertain the extent to which chlorpropamide potentiates a vasopressin-induced antidiuresis in the DI rat. The results of one such experiment, using female adult Brattleboro DI rats treated daily with 25 mu 'Pitressin'j24h and various doses of chlorpropamide (5, 10 and 20 mgj24h) are shown in Fig. 3 . All drug doses were administered by subcutaneous injection for 4 days. Water intake was estimated daily as an indication of the decrease in urine excretions induced by the various treatments. The use of this parameter to determine (indirectly) the extent of any antidiuresis meant that the animals could be kept in normal plastic cages rather than be maintained in metabolism cages. Even with the large dose of chlorpropamide (20 mgj24h), corresponding to some 1000 mgj24h to a 70 kg human patient on the basis of surface-area ratios, the maximum potentiation of the 'Pitressin'-induced decrease in water metabolism was only by some 13-8 %.
Another experiment, designed to study not only changes in water intake, but also urine volumes and osmolalities and solute excretions was carried out on Brattleboro DI rats using a latin square experimental design (Fig. 4) . The daily trends of the drug potentiation at 2 levels of 'Pitressin' (25 and 50 muj24h) by 5 mg chlorpropamidej24h indicated very little, if any, drug effect on any of the 4 variables studied, Indeed no significant drug effect could be measured on any of the 4 days of treatment, although a significant 'Pitressin' dose-effect was present (P<0·05).
The conclusion drawn from these, and other, experiments was that chlorpropamide did have some potentiating action on the antidiuretic effect of small, circulating amounts of vasopressin, but that some other much more important mechanism of action for the drug must exist to account for the clinically important antidiuresis observed in many DI patients.
In an attempt to determine whether chlorpropamide might have a more important action on the synthesis or release mechanisms for vasopressin, glucose-hydrated heterozygous Brattleboro rats were used. The addition of dextrose to the drinking water to a final concentration of 5 % was sufficient to increase (voluntarily) the fluid intakes and urine excretions of the heterozygous Brattleboro rats to levels comparable with those of their homozygous DI counterparts. These hydrated heterozygous rats were responsive to exogenous vasopressin ('Pitressin'), with a dose of 1000 mu 'Pitressin' j24h again being the dose required to restore water balance in these animals to normal hydropenic values (Laycock, Lee & Lewis, 1974) . The glucose-hydrated heterozygous rats were then treated with chlorpropamide (20 mgj24h) daily for 8 days, these animals being simultaneously treated with 25 mu Pitressinj24h during the last 4 days of the experimental period (Fig. 5 ). Again chlorpropamide alone had no antidiuretic effect, and even in the presence of small amounts of circulating vasopressin there was no noticeable potentiating action. It could be, however, that the dose of chlorpropamide administered was in- sufficient to overcome the polydipsic stimulus of the 5 % glucose solution, and therefore did not cause the release of sufficient vasopressin to induce a significant antidiuresis (Laycock, Lee & Lewis, 1974) . Unfortunately, with even higher doses of chlorpropomide (i.e. greater than 20 mg/24h) the problem of inducing hypoglycaemia then becomes difficult to overcome. Days Fig. 5 . Effect of chlorpropamide 20 mg/24h (e) alone and combined with 'Pitressin' 25 mu/24h (.) on the daily mean fluid intakes of 8 glucose-hydrated heterozygous Brattleboro rats. The median control value is given (0) together with its range, to indicate the degree of variation of control values: the horizontal line represents the lowest control value obtained. From Laycock, Lee & Lewis (1974) .
Another alternative which must be considered is that the Brattleboro rat homozygous and even heterozygous for the disease diabetes insipidus may have a further defect, possibly renal, which may account for the various observations made in the above experiments.
This possibility requires further investigation to justify, or disprove, the term "ideal experimental model' which has been assigned to the Brattleboro DI rat.
